1. Home
  2. CNTN vs IAF Comparison

CNTN vs IAF Comparison

Compare CNTN & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canton Strategic Holdings Inc. Common Stock

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$2.32

Market Cap

146.5M

Sector

Health Care

ML Signal

N/A

Logo abrdn Australia Equity Fund Inc.

IAF

abrdn Australia Equity Fund Inc.

N/A

Current Price

$13.18

Market Cap

120.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CNTN
IAF
Founded
2017
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
146.5M
120.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CNTN
IAF
Price
$2.32
$13.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
575.8K
19.3K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
11.44%
EPS Growth
88.10
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$4.36
52 Week High
$5.27
$14.54

Technical Indicators

Market Signals
Indicator
CNTN
IAF
Relative Strength Index (RSI) 55.56 47.24
Support Level $2.14 $13.09
Resistance Level $2.40 $13.21
Average True Range (ATR) 0.16 0.14
MACD 0.02 -0.05
Stochastic Oscillator 77.43 5.26

Price Performance

Historical Comparison
CNTN
IAF

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About IAF abrdn Australia Equity Fund Inc.

Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.

Share on Social Networks: